A phase 1, open-label, dose-escalating study to evaluate the safety, tolerability and immunogenicity of recombinant botulinum vaccine A/B in healthy adults

Trial Profile

A phase 1, open-label, dose-escalating study to evaluate the safety, tolerability and immunogenicity of recombinant botulinum vaccine A/B in healthy adults

Completed
Phase of Trial: Phase I

Latest Information Update: 22 Aug 2012

At a glance

  • Drugs Botulism vaccine (Primary)
  • Indications Botulism
  • Focus Adverse reactions
  • Most Recent Events

    • 28 Sep 2008 Actual end date (Aug 2005) added as reported by CT.gov
    • 28 Sep 2008 Status changed from recruiting to completed as reported by CT.gov
    • 22 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top